Published: Jan. 1, 2024
Language: Английский
Published: Jan. 1, 2024
Language: Английский
Experimental Neurology, Journal Year: 2025, Volume and Issue: 386, P. 115143 - 115143
Published: Jan. 11, 2025
Language: Английский
Citations
0Stem Cell Research & Therapy, Journal Year: 2025, Volume and Issue: 16(1)
Published: April 20, 2025
Idiopathic pulmonary fibrosis is a progressive lung disorder, presenting clinically with symptoms such as shortness of breath and hypoxemia. Despite its severe prognosis limited treatment options, the pathogenesis idiopathic remains poorly understood. This study aims to investigate therapeutic potential mesenchymal stromal cells in treating fibrosis, focusing on their ability modulate regulatory T through low tumor necrosis factor superfamily member 4 (TNFSF4) pathway. The goal identify subtypes optimal immunomodulatory effects enhance functions ameliorate fibrosis. We identified immune characteristics by mining analyzing multiple public datasets detecting blood tissues patients. An extensive examination followed, including assessing impact proportions peripheral tissue, exploring specific role TNFSF4 expression modulation. Whole-genome sequencing cluster analysis were used expression. Mesenchymal characterized (TNFSF4low-MSCs) demonstrated enhanced regulate subpopulations exhibited pronounced anti-fibrotic bleomycin-induced mouse model. These increased proportions, reduced improved survival rates. TNFSF4-tumor receptor (TNFRSF4) signaling was critical pathway influencing generation function. Our findings underscore pivotal mediated modulation highlight selecting based for approach may offer novel avenue development targeted therapies aimed at modulating responses ameliorating involved collecting 10 mL from patients, Medical Ethics Committee Nanjing Drum Tower Hospital approved our protocol approval number 2023-675-01.
Language: Английский
Citations
0Cytotherapy, Journal Year: 2024, Volume and Issue: 26(12), P. 1522 - 1531
Published: July 6, 2024
Language: Английский
Citations
1Published: Jan. 1, 2024
Language: Английский
Citations
0